63379-023 : Arzerra 20 mg/ml Intravenous Injection, Solution


NDC: 63379-023
Labeler: Glaxo Operations Uk Ltd
Product Type: Human Prescription Drug
Drug Name:  Arzerra
Dosage Form: Intravenous Injection, Solution
Application #: BLA125326
Rev. Date: 


NDC Package Codes:

  • 63379-023-01: 3 VIAL IN 1 CARTON (63379‑023‑01) > 5 ML IN 1 VIAL (63379‑023‑00)
  • 63379-023-02: 1 VIAL IN 1 CARTON (63379‑023‑02) > 50 ML IN 1 VIAL

Active Ingredients:

  • Ofatumumab

Dosage Strength:

  • 20 mg/mL

Pharmaceutical Classes:

  • CD20-directed Cytolytic Antibody [EPC]
  • CD20-directed Antibody Interactions [MoA]

Related Products:

Based on records with the same trade name.
  • 0078-0669 Arzerra 20 mg/ml Intravenous Injection, Solution by Novartis Pharmaceuticals Corporation
  • 0078-0690 Arzerra 20 mg/ml Intravenous Injection, Solution by Novartis Pharmaceuticals Corporation
  • 0173-0821 Arzerra 20 mg/ml Intravenous Injection, Solution by Glaxosmithkline LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63379-023 QR Code

< Prev: 63379-018Next: 63379-025 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.